Meen-Hsin Tsai

Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma

Jeng‐Sen Tseng, Tsung‐Ying Yang, Chi‐Ren Tsai et al. · Journal of Thoracic Oncology · 2014 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma

Jeng‐Sen Tseng, Tsung‐Ying Yang, Kun‐Chieh Chen et al. · OncoTargets and Therapy · 2014 · 17 citations · Full text

Medicine, Oncology, Pharmacology +12

Impact of EGFR Mutation Detection Methods on the Efficacy of Erlotinib in Patients with Advanced EGFR-Wild Type Lung Adenocarcinoma

Jeng‐Sen Tseng, Chih‐Liang Wang, Ming‐Shyan Huang et al. · PLoS ONE · 2014 · 13 citations · Full text

Medicine, Molecular Medicine, Oncology +17